Sapporo Clinical Laboratory Inc. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sapporo Clinical Laboratory Inc. with three other
drug stores in Asia:
Medical Ikkou Co Ltd
sales of 29.49 billion Japanese Yen [US$262.75 million]
of which 75%
Colombo City Holdings PLC
of Sri Lanka
(27.68 million Sri Lanka Rupees [US$180,190.20 ]
Caring Pharmacy Group Bhd
based in Malaysia
(459.96 million Malaysian Ringgits [US$108.89 million]
During the year ended March of 2017, sales at
Sapporo Clinical Laboratory Inc. were ¥17.06 billion (US$151.96 million).
decrease of 2.7%
versus 2016, when the company's sales were ¥17.53 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Sapporo Clinical Laboratory Inc. had sales
of ¥15.54 billion.
Contributing to the drop in overall sales was the 7.9% decline
in Medical Equipment Sales and Maintenance , from ¥1.02 billion to ¥941.74 million.
There were also decreases in sales in
Dispensing Pharmacy Business (down 4.0% to ¥10.57 billion)
However, these declines were partially offset by the increase in sales of
Clinical Testing Business (up 0.9% to ¥5.48 billion)
Other Businesses (up 0.3% to ¥68.56 million)